Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment.
作者信息
Villani Alessia, Fabbrocini Gabriella, Costa Claudia, Scalvenzi Massimiliano
机构信息
Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
出版信息
J Am Acad Dermatol. 2020 Jun;82(6):e205. doi: 10.1016/j.jaad.2020.03.057. Epub 2020 Mar 31.
Abstract
摘要
相似文献
1
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment.在2019冠状病毒病（COVID-19）期间接受音猬因子抑制剂治疗的晚期基底细胞癌患者：管理与治疗依从性
J Am Acad Dermatol. 2020 Jun;82(6):e205. doi: 10.1016/j.jaad.2020.03.057. Epub 2020 Mar 31.
2
Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice.音猬因子信号通路抑制剂：从临床试验到临床实践
Br J Dermatol. 2019 May;180(5):1260-1261. doi: 10.1111/bjd.17692. Epub 2019 Mar 7.
3
Hedgehog Pathway Inhibition.刺猬通路抑制。
Cell. 2016 Feb 25;164(5):831. doi: 10.1016/j.cell.2016.02.021.
4
COVID-19 Board: Our Multidisciplinary Cutaneous Oncology Tumor Board During the Coronavirus-19 Pandemic.COVID-19 病例讨论会：新冠疫情期间我们的多学科皮肤肿瘤病例讨论会
Dermatol Surg. 2020 Sep;46(9):1224-1225. doi: 10.1097/DSS.0000000000002568.
5
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic.使用索尼德吉仅治疗3个月后晚期基底细胞癌完全缓解：1例报告及COVID-19大流行期间的药物管理
Dermatol Ther. 2020 Nov;33(6):e14200. doi: 10.1111/dth.14200. Epub 2020 Sep 14.
6
Oral hedgehog-pathway inhibitors for basal-cell carcinoma.用于基底细胞癌的口服刺猬信号通路抑制剂
N Engl J Med. 2012 Jun 7;366(23):2225-6. doi: 10.1056/NEJMe1202170.
7
Vismodegib in advanced basal-cell carcinoma.维莫德吉用于晚期基底细胞癌
N Engl J Med. 2012 Sep 6;367(10):969-70; author reply 970. doi: 10.1056/NEJMc1208003.
8
Vismodegib in advanced basal-cell carcinoma.维莫德吉用于晚期基底细胞癌
N Engl J Med. 2012 Sep 6;367(10):970; author reply 970-1. doi: 10.1056/NEJMc1208003.
9
Sonidegib (Odomzo) for basal cell carcinoma.用于基底细胞癌的索尼德吉（奥多姆佐）
Med Lett Drugs Ther. 2016 Feb 29;58(1489):31-2.
10
Systemic treatments for basal cell carcinoma (BCC): the advent of dermato-oncology in BCC.基底细胞癌（BCC）的系统治疗：BCC 中的皮肤肿瘤学出现。
Br J Dermatol. 2013 Jul;169(1):53-7. doi: 10.1111/bjd.12311.
引用本文的文献
1
The impact of the COVID-19 pandemic on the diagnosis and treatment of skin cancers, a mini review.COVID-19 大流行对皮肤癌的诊断和治疗的影响，小型综述。
Cancer Rep (Hoboken). 2023 Sep;6(9):e1854. doi: 10.1002/cnr2.1854. Epub 2023 Jul 12.
2
Treatment Adherence in Dermatology During the COVID-19 Pandemic: A Review.COVID-19大流行期间皮肤科的治疗依从性：一项综述
Cureus. 2023 Jan 24;15(1):e34141. doi: 10.7759/cureus.34141. eCollection 2023 Jan.
3
Clinical Dermatology and COVID-19 Pandemic: Narrative Review.临床皮肤病学与新冠疫情：叙述性综述
Indian J Dermatol. 2021 May-Jun;66(3):246-255. doi: 10.4103/ijd.ijd_463_21.
4
Topological network based drug repurposing for coronavirus 2019.基于拓扑网络的 2019 年冠状病毒药物再利用
PLoS One. 2021 Jul 29;16(7):e0255270. doi: 10.1371/journal.pone.0255270. eCollection 2021.
5
Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review.由于 COVID-19 大流行导致的癌症医疗保健延误和中断：系统评价。
JCO Glob Oncol. 2021 Feb;7:311-323. doi: 10.1200/GO.20.00639.
6
The Multifaceted Engagement of the Dermatologist in the Covid-19 Pandemic.皮肤科医生在新冠疫情中的多方面参与
SN Compr Clin Med. 2020;2(9):1388-1392. doi: 10.1007/s42399-020-00423-9. Epub 2020 Jul 22.
7
Impact of COVID-19 Pandemic on Dermatologists and Dermatology Practice.2019冠状病毒病大流行对皮肤科医生及皮肤科医疗实践的影响
Indian Dermatol Online J. 2020 May 10;11(3):328-332. doi: 10.4103/idoj.IDOJ_180_20. eCollection 2020 May-Jun.
8
Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.COVID-19 大流行中的皮肤表现和注意事项：系统评价。
Dermatol Ther. 2020 Nov;33(6):e13986. doi: 10.1111/dth.13986. Epub 2020 Aug 6.
9
Management of patients with melanoma and non-melanoma skin cancers in the coronavirus disease 2019 era.2019冠状病毒病时代黑色素瘤和非黑色素瘤皮肤癌患者的管理
Chin Med J (Engl). 2020 Sep 5;133(17):2017-2019. doi: 10.1097/CM9.0000000000000930.
10
COVID-19 and dermatology: a comprehensive guide for dermatologists.新型冠状病毒肺炎与皮肤病学：皮肤科医生实用指南。
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1388-1394. doi: 10.1111/jdv.16545. Epub 2020 Jun 10.
本文引用的文献
1
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
2
Infection control in the outpatient setting.门诊环境中的感染控制。
Infect Control Hosp Epidemiol. 1998 Jan;19(1):41-74. doi: 10.1086/647706.
Zotero 插件